# Punto Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/punto-health

- Industry: Software
- Headquarters: London, UK
- Website: www.puntohealth.com
- Total disclosed funding: $3.5M
- Latest round: Seed (Nov 5, 2025)
- Investors on record: 6

## About

Founded in 2023 and based in London, UK, Punto Health Ltd. operates as a digital healthcare company. The company was founded by its CEO, Anna Muñoz Farré, and Jack Eckersley. In December 2025, Punto Health Ltd. raised GBP 2 million in seed funding co-led by Shilling Capital Partners and Plus Partners, with participation from Exceptional Ventures, Social Stock Fund, Abac Capital, and Heartfelt Capital Management.
 Punto Health develops AI-driven tools for cognitive care, focusing on dementia. The company’s product line includes PuntoCare, an AI-powered assistant designed for patients and caregivers that provides information, resources, and support for managing the disease at home; and PuntoClinic, a platform for managing and monitoring cognitive health that utilizes digital biomarkers for cognitive assessment and integrates other available tests. The company plans to use the December 2025 funding to accelerate product development and expand its commercial presence in the UK and Spain.

## Funding rounds

- Seed, Nov 5, 2025, $3.5M — Abac Capital, Shilling Capital Partners, Social Stock Fund, Exceptional Ventures, Heartfelt Capital Management, Plus Partners

## Investors

- Abac Capital (https://capitalatlas.ai/funds/abac-capital) — Seed
- Shilling Capital Partners (https://capitalatlas.ai/funds/shilling-capital-partners) — Seed
- Social Stock Fund — Seed
- Exceptional Ventures (https://capitalatlas.ai/funds/exceptional-ventures) — Seed
- Heartfelt Capital Management (https://capitalatlas.ai/funds/heartfelt-capital-management) — Seed
- Plus Partners (https://capitalatlas.ai/funds/plus-partners) — Seed